Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACTS: Varespladib for Prevention of Acute Chest Syndrome in Sickle Cell Disease
NCT00434473Phase 2Completed
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- Dec 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varespladib in acute chest syndrome (ACS), sponsored by Anthera Pharmaceuticals, Inc.. Started Dec 2006; status: completed.
02
Drugs
varespladib
03
Conditions
acute chest syndrome (ACS)
Beyond the preview
Go deeper on NCT00434473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434473.